CYLEMBIO
LIVE

Serial Number

79382512

Owner

IO Biotech ApS

Attorney

Bryce J. Maynard

Filing Date

Sep 20, 2023

Add to watchlist:

No watchlists yet
View on USPTO

CYLEMBIO Trademark

Serial Number: 79382512

CYLEMBIO is a trademark filed by IO Biotech ApS on September 20, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

IO Biotech ApS (10 trademarks)

Ole Maaløes Vej 3

Entity Type: 99

Trademark Details

Filing Date

September 20, 2023

Registration Date

Not Registered

Published for Opposition

January 7, 2025

Goods & Services

Pharmaceutical preparations for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, infection and immune system related diseases; pharmaceutical drugs and pharmaceutical substances for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, infection and immune system related diseases; synthetic peptides for pharmaceutical use for the prevention and treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric, infection and immune system related diseases; vaccines

Filing History

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 1, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 11, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 24, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 24, 2024 CRFA
ASSIGNED TO LIE
Oct 24, 2024 ALIE
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jul 17, 2024 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 29, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 29, 2024 GNSL
SUSPENSION LETTER WRITTEN
Feb 29, 2024 CNSL
EXAMINER'S AMENDMENT ENTERED
Feb 29, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 29, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 29, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 29, 2024 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 31, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 31, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 31, 2024 TROA
REFUSAL PROCESSED BY IB
Jan 23, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 2, 2024 RFCS
REFUSAL PROCESSED BY MPU
Jan 2, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 21, 2023 RFCR
NON-FINAL ACTION WRITTEN
Dec 20, 2023 CNRT
ASSIGNED TO EXAMINER
Dec 18, 2023 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 10, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 6, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 2, 2023 REPR